stockrow
Friday 6 November 2026
Export ALC’s income statement to Excel — free account
Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
76.45
0.86
−1.11%
Follow ALC
Alert me
Alcon (ALC) EBITDA
Alcon's EBITDA for fiscal 2025 was $2.6B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.7B. Over the past ten years it has ranged from $1.1B (fiscal 2020) to $2.6B (fiscal 2024); the current reading is higher than 90% of that period. Alcon ranks 4th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $2.6B | (3.33%) |
| FY2024 | $2.6B | 16.51% |
| FY2023 | $2.3B | 27.03% |
| FY2022 | $1.8B | (0.94%) |
| FY2021 | $1.8B | 57.34% |
| FY2020 | $1.1B | (9.85%) |
| FY2019 | $1.3B | (7.64%) |
| FY2018 | $1.4B | 11.37% |
| FY2017 | $1.2B | (1.69%) |
| FY2016 | $1.3B | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $804.0M | 28.85% |
| Mar 2026 | $624.0M | (3.26%) |
| Dec 2025 | $645.0M | (2.57%) |
| Sep 2025 | $662.0M | 8.88% |
| 28 more quarters | Free account |
Against its own ten years
Low $1.1B
High $2.6B
Ten-year median
$1.6B
Current reading's percentile
90
EBITDA against peers
| Company | EBITDA |
|---|---|
| MDLN Medline Inc. compare | $10.0B |
| BDX Becton, Dickinson and Company compare | $4.8B |
| ALC Alcon | $2.7B |
| SOLV Solventum Corporation compare | $2.6B |
| RMD ResMed Inc. compare | $2.1B |
| BAX Baxter International Inc. compare | $1.5B |
| WST West Pharmaceutical Services, Inc. compare | $964.5M |
| COO The Cooper Companies, Inc. compare | $928.2M |
| ALGN Align Technology, Inc. compare | $802.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ALC
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement